Komori
CellSource (4880) · RiskRestated

Reputational damage and medical accident risks associated with regenerative medicine

First written in FY2019. 3 of 4 entries say "Restated". Latest entry: FY2022.

4entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019 – FY20222020: 120202021: 120212022: 120222023: 1
Same theme, other companies
Reputational damage caused by medical accidents and illegal acts in the regenerative medicine industryA theme 2 companies write about · 2 as a headwind · 0 as a tailwind

0 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2022RestatedAnnual report

    「If a violation of laws or regulations by a medical institution or other party, treatment that disadvantages patients, or an incident causing severe symptoms as a result of illegal treatment, medical malpractice or other factors occurs at a medical institution or other facility in the future, it could cause reputational damage to regenerative medicine as a whole」

    The risk of industry-wide reputational damage resulting from violations of laws or regulations, medical malpractice and unexpected treatment outcomes at other medical institutions and facilities remains.
  2. FY2021RestatedAnnual report

    「If a violation of laws or regulations by a medical institution or other party, treatment that disadvantages patients, or an incident causing severe symptoms as a result of illegal treatment, medical malpractice or other factors occurs at a medical institution or other facility in the future, it could cause reputational damage to regenerative medicine as a whole」

    The risk of reputational damage to regenerative medicine as a whole resulting from violations of laws or regulations, medical malpractice and unexpected treatment outcomes at other medical institutions and facilities remains.
  3. FY2020RestatedAnnual report

    「If a violation of laws or regulations by a medical institution or other party, treatment that disadvantages patients, or an incident causing severe symptoms as a result of illegal treatment, medical malpractice or other factors occurs, it could cause reputational damage to regenerative medicine as a whole」

    The risk of industry-wide reputational damage resulting from illegal acts, medical malpractice and unexpected treatment outcomes by other companies and medical institutions remains.
  4. FY2019First statedAnnual report

    「If a violation of laws or regulations by a medical institution or other party, treatment that disadvantages patients, or an incident causing severe symptoms as a result of illegal treatment, medical malpractice or other factors occurs, it could cause reputational damage to regenerative medicine as a whole」

    The company identifies as risks not only direct problems with its own services, but also industry-wide reputational damage resulting from illegal acts, medical malpractice and unexpected treatment outcomes within the industry.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for CellSource yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Reputational damage and medical accident risks associated with regenerative medicine | CellSource Co.,Ltd. (4880) | Komori